SLC2A4 and Insulin resistance: Research has demonstrated that agents capable of inhibiting pro‐inflammatory activation while simultaneously promoting anti‐inflammatory activation of macrophages in epWAT may enhance GLUT4 expression in these tissues, thereby potentially ameliorating insulin resistance (Olefsky and Glass 2010).